
Innovation at the Intersection of Digital Health and Real-World Evidence
“Real-World Evidence (RWE) solutions market is expected to grow at a CAGR of 13.9% within 2026 to reach $1.64 billion by 2026 and will see higher traction while becoming a key differentiator for market leaders across all major stakeholders in health system including Manufacturers, Payers, Providers & Regulators. Therefore, it is imperative to understand the landscape of digital health innovation, challenges and opportunities revolving journey of real-world data to real-world evidence.”
RELATED TAGS